Conversation Guides

NRC Banner 23

Talking about COVID-19 vaccines while building trust

Dispelling myths and alleviating apprehensions around vaccination requires a trusted relationship and a safe, non-judgmental environment for individuals to voice their concerns and ask questions. These guides equip readers with the skills to answer questions about COVID-19 vaccines and participate in conversations with others, ultimately supporting vaccine confidence in their communities.

Choose a topic for frequently asked questions and helpful responses as well as additional resources to give to your contacts who wish to seek out additional information.

General Conversation Guide

General Questions

This webpage is designed to help client-facing staff competently respond to common vaccine questions. It lists frequently asked questions and helpful responses as well as provides additional resources to give to clients who wish to seek out additional information.

Learn more >>

Boosters Conversation Guide

Boosters + Third Doses

People with certain health conditions need three shots to become protected against COVID-19. People who have a higher risk of catching COVID-19 or getting seriously ill should have a booster to make sure they stay protected. While boosters may increase protection, people who are fully vaccinated continue to have good protection against severe illness and hospitalization without a booster.

Learn more >>

Delta Conversation Guide

Breakthrough Infections

It is uncommon for people to get COVID-19 after they are vaccinated, but it can happen. Scientists call this a “breakthrough infection.” COVID-19 vaccines are effective at preventing infection, serious illness, and death. However, since vaccines are not 100% effective at preventing infection, some people who are fully vaccinated will still get COVID-19.

Learn more >>

Children and Youth Conversation Guide

Children and Youth

To help stop the spread of COVID-19, it is important to vaccinate people as soon as they are eligible. Right now, that means everyone age 12 and up. Widespread vaccination is the key to being able to go back to pre-pandemic activities, such as in-person classes, after-school activities, social gatherings, and travel. 

Learn more >>

Delta Conversation Guide

Delta Variant

The Delta variant is one of the COVID-19 variants that scientists are monitoring. Experts are worried about the Delta variant for two main reasons. First, the Delta variant spreads much more easily between people. Second, there is also concern that the Delta variant might cause more severe illness. It was first found in the U.S. in March 2021 and is already the most common variant in the United States.

Learn more >>

Employer requirements Conversation Guide

Employer Requirements

With increasing numbers of organizations and businesses requiring vaccinations, it is understandable that employees have questions. For workers in refugee, immigrant and migrant communities, language and other barriers can make it more difficult to have these questions answered by their work supervisor or human resources representative. Instead, they may bring these questions to client-facing staff in refugee service agencies and community-based organizations.

Learn more >>

Fertility Conversation Guide

Fertility + Parenthood

COVID-19 vaccines do not affect people’s ability to have children. There is no evidence the vaccines affect women’s ability to get pregnant, nor do they affect men’s reproductive ability. COVID-19 vaccines are also safe for caregivers who are pregnant or breastfeeding.

Learn more >>

Masking conversation guide

Wearing a Mask

Whether you have been vaccinated or not, it's safest to wear a mask. While getting vaccinated is the most important step for you to take to protect yourself and your community, wearing a mask provides even more protection. Masks protect you and people around you from getting COVID-19.

Learn more >>

JJ Vaccine Conversation Guide

Johnson & Johnson

In April 2020, there was a temporary pause on the Johnson & Johnson (J&J) vaccine in order to study a few incidences of a rare type of blood clot in individuals (women between 18 and 59 ) who received the J&J vaccine. On April 23, The CDC recommend resuming use of J&J because the benefit of the vaccine far outweighs any risk from it.

Learn more >>